​
​

Corcept Therapeutics Ownership | Who Owns Corcept Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Corcept Therapeutics Ownership Summary

Corcept Therapeutics is owned by 86.81% institutional investors, 11.52% insiders, and 1.67% retail investors. Blackrock is the largest institutional shareholder, holding 16.09% of CORT shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.65% of its assets in Corcept Therapeutics shares.

CORT Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCorcept Therapeutics86.81%11.52%1.67%
SectorHealthcare Stocks 47.25%8.01%44.75%
IndustryBiotech Stocks 45.35%7.81%46.83%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF5.92M5.65%5.24K
Vanguard Total Stock Mkt Idx Inv2.81M2.68%-14.35K
Vanguard Small Cap Index2.23M2.13%4.35K
iShares Russell 2000 ETF2.08M1.98%-4.66K
Vanguard Institutional Extnd Mkt Idx Tr1.39M1.32%-28.10K
Vanguard Small Cap Growth Index Inv1.22M1.17%-1.68K
First Trust NYSE Arca Biotech ETF866.25K0.83%-
Fidelity Small Cap Index827.31K0.79%-20.70K
SPDR® Portfolio S&P 600™ Sm Cap ETF821.88K0.78%6.20K
iShares Russell 2000 Growth ETF720.49K0.69%-

Recent Insider Transactions

DateNameRoleActivityValue
Nov 11, 2024Swisher Daniel N JR-Sell$131.74K
Nov 04, 2024Guyer William Chief Development OfficerSell$166.20K
Oct 01, 2024Guyer William Chief Development OfficerSell$462.80K
Oct 01, 2024Robb Gary Charles Chief Business OfficerSell$509.08K
Sep 03, 2024Guyer William Chief Development OfficerSell$353.00K

Insider Transactions Trends

DateBuySell
2024 Q4-4
2024 Q3-8
2024 Q2-12
2024 Q1-8
2023 Q4-17

CORT Ownership FAQ

Who Owns Corcept Therapeutics?

Corcept Therapeutics shareholders are primarily institutional investors at 86.81%, followed by 11.52% insiders and 1.67% retail investors. The average institutional ownership in Corcept Therapeutics's industry, Biotech Stocks , is 45.35%, which Corcept Therapeutics exceeds.

Who owns the most shares of Corcept Therapeutics?

Corcept Therapeutics’s largest shareholders are Blackrock (16.54M shares, 16.09%), Vanguard group (9.55M shares, 9.29%), and Renaissance (6.91M shares, 6.72%). Together, they hold 32.11% of Corcept Therapeutics’s total shares outstanding.

Does Blackrock own Corcept Therapeutics?

Yes, BlackRock owns 16.09% of Corcept Therapeutics, totaling 16.54M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 537.36M$. In the last quarter, BlackRock decreased its holdings by -287K shares, a -1.71% change.

Who is Corcept Therapeutics’s biggest shareholder by percentage of total assets invested?

Tanaka capital management is Corcept Therapeutics’s biggest shareholder by percentage of total assets invested, with 7.71% of its assets in 100.28K Corcept Therapeutics shares, valued at 3.26M$.

Who is the top mutual fund holder of Corcept Therapeutics shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Corcept Therapeutics shares, with 5.65% of its total shares outstanding invested in 5.92M Corcept Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools